Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001181431-12-065223
Filing Date
2012-12-17
Accepted
2012-12-17 18:58:59
Documents
2
Period of Report
2012-12-13

Document Format Files

Seq Description Document Type Size
1 FORM 3 rrd363879.html 3  
1 FORM 3 rrd363879.xml 3 1585
2 POWER OF ATTORNEY rrd326627_369206.htm EX-24. 3030
  Complete submission text file 0001181431-12-065223.txt   6130
Mailing Address 5 CENTERPOINTE DRIVE, SUITE 400 LAKE OSWEGO OR 97035
Business Address 5 CENTERPOINTE DRIVE, SUITE 400 LAKE OSWEGO OR 97035 971-2040382
CYTODYN INC (Issuer) CIK: 0001175680 (see all company filings)

EIN.: 753056237 | State of Incorp.: CO | Fiscal Year End: 0531
SIC: 2834 Pharmaceutical Preparations

Mailing Address 5 CENTERPOINTE DRIVE, SUITE 400 LAKE OSWEGO OR 97305
Business Address
Mulholland Michael D. (Reporting) CIK: 0001257911 (see all company filings)

Type: 3 | Act: 34 | File No.: 000-49908 | Film No.: 121269695